Reliability of the histophalogic diagnosis of melanocytic dysplasia

Archives of Dermatology

Volumn 133, Issue 8, 1997, Pages 953-958

  Weinstock, Martin A ^a,e   Barnhill, Raymond L ^b   Rhodes, Arthur R ^c   Brodshy, Gilbert L ^d  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

^e PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CASE CONTROL STUDY; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DYSPLASTIC NEVUS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; CONFIDENCE INTERVAL; DERMATOLOGY; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; SKIN TUMOR; STATISTICS;

CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DERMATOLOGY; DYSPLASTIC NEVUS SYNDROME; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS;

EID: 0031203553     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.8.953     Document Type: Article

References (32)

1. Weinstock MA. Dysplastic nevi revisited. J Am Acad Dermatol. 1994;30:807-810.
2. Roth ME, Grant-Kels JM, Ackerman AB, et al. The histopathology of dysplastic nevi: continued controversy. Am J Dermatopathol. 1991;13:38-51.
3. Rhodes AR, Mihm MC Jr, Weinstock MA. Dysplastic melanocytic nevi: a repro ducible histologic definition emphasizing cellular morphology. Mod Pathol. 1989; 2:306-319.
4. Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol. 1991;22:313-319.
5. Piepkorn MW, Barnhill RL, Cannon-Albright LA, et al. A multi-observer, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol. 1994;30:707-714.
6. Zar JH. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1984.
7. Agresti A. Analysis of Ordinal Categorical Data. New York, NY: John Wiley & Sons Inc; 1984.
8. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ. 1992;304:1491-1494.
9. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-220.
10. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613-619.
11. Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987;126:161-169.
12. Byrt T, Bishop J, Carlin JB. Bias, prevalence, and kappa. J Clin Epidemiol. 1993; 46:423-429.
13. Graham P, Jackson R. The analysis of ordinal agreement data: beyond weighted kappa. J Clin Epidemiol. 1993;46:1055-1062.
14. Sagebiel RW, Banda PW, Schneider JS, Crutcher WA. Age distribution and histologic patterns of dysplastic nevi. J Am Acad Dermatol. 1985;13:975-982.
15. Heenan PJ, Matz LR, Blackwell JB, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathology. 1984;8:717-729.
16. Colloby PS, West KP, Fletcher A. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol. 1991; 163:245-250.
17. Walter SD, Marrett LD, Hertzman C. Reliability of interviewer and subject assessments of nevus counts in a study of melanoma. J Clin Epidemiol. 1991;44: 633-640.
18. Leffell DJ, Chen Y-T, Berwick M, Bolognia JL. Interobserver agreement in a community skin cancer screening setting. J Am Acad Dermatol. 1993;28:1003-1005.
19. Carli P, Urso C, De Giorgi V, Biggeri A, Bondi R, Giannottii B. Sensitivity and specificity of clinical criteria in the detection of histologic atypia in nevi. Eur J Dermatol. 1994;4:35-39.
20. de Vet HCW, Knipschild PG, Schouten HJA, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol. 1990;43:1395-1398.
21. Stanganelli I, Burroni M, Rafanelli S, Bucchi L. Intraobserver agreement in interpretation of digital epiluminescence microscopy. J Am Acad Dermatol. 1995; 33:584-589.
22. Whited JD, Horner RD, Hall RP, Simel DL. The influence of history on interobserver agreement for diagnosing actinie keratoses and malignant skin lesions. J Am Acad Dermatol. 1995;33:603-607.
23. Meyer LJ, Piepkorn M, Goldgar DE, et al. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. J Am Acad Dermatol. 1996;34:618-625.
24. Lock-Andersen J, Hou-Jensen K, Hansen JPH, Jensen NK, Sogaard H, Andersen PK. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Hand Surg. 1995;29:141-148.
25. Schmoeckel C. How consistent are dermatopathologists in reading early malignant melanomas and lesions 'precursor' to them? an international survey. Am J Dermatopathol. 1984;6(suppl):13-24.
26. Krieger N, Hiatt RA, Sagebiel RW, Clark WH, Mihm MC. Inter-observer variability among pathologists' evaluation of malignant melanoma: effect upon an analytic study. J Clin Epidemiol. 1994;47:897-902.
27. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14:1218-1223.
28. Duray PH, DerSimonian R, Barnhill RL, et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol. 1992;27:741-749.
29. Duncan LM, Berwick M, Bruijn JA, Byers HR, Mihm MC, Barnhill RL. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol. 1993;100(suppl):318S-321S.
30. Ahmed I, Peipkorn MW, Rabkin MS, et al. Histopathologic characteristics of dysplastic nevi: limited association of conventional histologic criteria with melanoma risk group. J Am Acad Dermatol. 1990;22:727-733.
31. de Wit PEJ, van't Hof-Grootenboer B, Ruiter DJ, et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi: an interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer. 1993;29A:831-839.
32. Hastrup N, Clemmensen OJ, Spaun E, Sondergaard K. Dysplastic naevus: histologic criteria and their inter-observer reproducibility. Histopathology. 1994; 24:503-509.